Literature DB >> 7876851

Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease.

N R Swerdlow1, J Paulsen, D L Braff, N Butters, M A Geyer, M R Swenson.   

Abstract

The corpus striatum serves a critical function in inhibiting involuntary, intrusive movements. Striatal degeneration in Huntington's disease results in a loss of motor inhibition, manifested by abnormal involuntary choreiform movements. Sensorimotor inhibition, or "gating", can be measured in humans using the startle reflex: the startle reflex is normally inhibited when the startling stimulus is preceded 30-500 ms earlier by a weak prepulse. In the present study, prepulse inhibition (PPI) was measured in patients with Huntington's disease to quantify and characterise sensorimotor gating. Compared with age matched controls, patients with Huntington's disease exhibit less PPI. Startle gating deficits are evident in patients with Huntington's disease when startle is elicited by either acoustic or tactile stimuli. Even with stimuli that elicit maximal PPI in normal subjects, patients with Huntington's disease exhibit little or no PPI, and their pattern of startle gating does not show the normal modulatory effects usually elicited by changing the prepulse interval or intensity. Startle amplitude and habituation and latency facilitation are largely intact in these patients, although reflex latency is significantly slowed. In patients with Huntington's disease, startle reflex slowing correlates with cognitive impairment measured by the dementia rating scale, and with the performance disruptive effects of interference measured by the Stroop test. These findings document a profound disruption of sensorimotor gating in patients with Huntington's disease and are consistent with preclinical findings that identify the striatum and striatopallidal GABAergic efferent circuitry as critical substrates for sensorimotor gating of the startle reflex.

Entities:  

Mesh:

Year:  1995        PMID: 7876851      PMCID: PMC1073317          DOI: 10.1136/jnnp.58.2.192

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

1.  Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease.

Authors:  N Butters; D Sax; K Montgomery; S Tarlow
Journal:  Arch Neurol       Date:  1978-09

2.  Huntington disease: clinical care and evaluation.

Authors:  I Shoulson; S Fahn
Journal:  Neurology       Date:  1979-01       Impact factor: 9.910

3.  Modification of the acoustic startle reflex by a tactile prepulse: the effects of stimulus onset asynchrony and prepulse intensity.

Authors:  T D Blumenthal; G A Gescheider
Journal:  Psychophysiology       Date:  1987-05       Impact factor: 4.016

4.  Prestimulus effects on human startle reflex in normals and schizophrenics.

Authors:  D Braff; C Stone; E Callaway; M Geyer; I Glick; L Bali
Journal:  Psychophysiology       Date:  1978-07       Impact factor: 4.016

5.  Speculations on the functional anatomy of basal ganglia disorders.

Authors:  J B Penney; A B Young
Journal:  Annu Rev Neurosci       Date:  1983       Impact factor: 12.449

6.  The measurement of abnormal movement: methods developed for Huntington's disease.

Authors:  S E Folstein; B Jensen; R J Leigh; M F Folstein
Journal:  Neurobehav Toxicol Teratol       Date:  1983 Nov-Dec

7.  A primary acoustic startle circuit: lesion and stimulation studies.

Authors:  M Davis; D S Gendelman; M D Tischler; P M Gendelman
Journal:  J Neurosci       Date:  1982-06       Impact factor: 6.167

8.  Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain.

Authors:  R Schwarcz; W O Whetsell; R M Mangano
Journal:  Science       Date:  1983-01-21       Impact factor: 47.728

9.  A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement.

Authors:  P M Groves
Journal:  Brain Res       Date:  1983-03       Impact factor: 3.252

10.  Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats.

Authors:  F J Wan; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more
  122 in total

1.  Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

Authors:  R J Carter; L A Lione; T Humby; L Mangiarini; A Mahal; G P Bates; S B Dunnett; A J Morton
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

2.  Developmental markers of psychiatric disorders as identified by sensorimotor gating.

Authors:  Susan B. Powell; Mark A. Geyer
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 3.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

4.  Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

Authors:  Boris B Quednow; Michael Kometer; Mark A Geyer; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

5.  Extended access to methamphetamine self-administration affects sensorimotor gating in rats.

Authors:  Martin Hadamitzky; Athina Markou; Ronald Kuczenski
Journal:  Behav Brain Res       Date:  2010-11-09       Impact factor: 3.332

Review 6.  Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-08-19       Impact factor: 8.989

7.  5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats.

Authors:  R A Padich; T C McCloskey; J H Kehne
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

8.  Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome.

Authors:  Neal R Swerdlow; Michele J Bongiovanni; Laura Tochen; Jody M Shoemaker
Journal:  Psychopharmacology (Berl)       Date:  2006-04-01       Impact factor: 4.530

9.  Meclizine enhancement of sensorimotor gating in healthy male subjects with high startle responses and low prepulse inhibition.

Authors:  José A Larrauri; Lisalynn D Kelley; Mason R Jenkins; Eric C Westman; Nestor A Schmajuk; M Zachary Rosenthal; Edward D Levin
Journal:  Neuropsychopharmacology       Date:  2013-09-18       Impact factor: 7.853

Review 10.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.